New 'Long COVID' Study , Could Lead to Future , Treatment Options.<br />BBC reports that people experiencing "long COVID" <br />have evidence of inflammation in their blood, which could <br />lead to further understanding and potential treatments.<br />A new study in the United Kingdom found the<br />presence of certain proteins increases the risk <br />for certain symptoms, including fatigue.<br />Long COVID is believed to impact <br />millions of people around the world. <br />Here are some of the most common symptoms.<br />Shortness of breath, Extreme tiredness, Brain fog.<br />Other symptoms of Long COVID can include <br />sleeping problems, loss of smell and anxiety.<br />The latest study by the Imperial College <br />London suggests that inflammation , "could be a common feature of long COVID after <br />hospitalization, regardless of symptom type.".<br />BBC reports that the findings suggest that existing drugs <br />used to treat other forms of inflammation, like <br />rheumatoid arthritis, could be effective against Long COVID.<br />This work provides strong evidence <br />that long Covid is caused by post-viral <br />inflammation but shows layers of complexity, Peter Openshaw, Lead research Professor, via BBC .<br />We hope that our work opens the way <br />to the development of specific tests <br />and treatments for the various types <br />of long Covid and believe that a <br />'one size fits all' approach to <br />treatment may not work, Peter Openshaw, Lead research Professor, via BBC .<br />The team's findings were published <br />in the journal 'Nature Immunology.'
